Northwestern University IRB: STU00201540
Principal Investigator:Crystal Clark, MD, MSc
Dr. Crystal Clark is currently conducting research on Seroquel (quetiapine), an FDA approved drug commonly used to treat Bipolar Disorder and Schizophrenia. Because Bipolar Disorder and Schizophrenia frequently affect women during their reproductive years, the goal of this research study is to understand how the dose of Seroquel should be modified for women who are pregnant. By participating in this study, you can help optimize the quality of care for women with Bipolar Disorder and Schizophrenia. At your initial visit, you will complete a full psychiatric evaluation with Dr. Clark at no cost to you. At each subsequent visit, you will stay overnight in the clinical research unit and complete assessments to monitor your mood, as well as blood draws to monitor your quetiapine levels. As compensation, you will receive reimbursement for on-site parking or public transportation, financial compensation between $100-200 for every study visit you complete, for a total of up to $575; medical consultation with Dr. Crystal Clark about the best treatment for you throughout pregnancy; gifts for you and your baby and careful monitoring of your symptoms throughout pregnancy.
Participants will be eligible for the study if they:
- Are between the ages of 18-45 years old
- Have a diagnosis of Bipolar Disorder or Schizophrenia
- Are in the first or second trimester of pregnancy
- Are taking a daily dose of Seroquel (quetiapine)
If you are interested in participating or would like to hear more information, please email research coordinator Rebecca Newmark or call 855-99-ASHER.